Cann Group takes steps to resume ASX trading as Q3 revenues tumble and cash flow worsens by Steve Jones April 30, 2024April 30, 2024 Cann Group endured a torrid third quarter as revenues tumbled and its net cash positioned worsened […]
Cann Group eyes A$15m capital injection from New York-based investment firm by Martin Lane March 25, 2024March 27, 2024
Cann Group receives final payment from Sativite for Southern facility by Martin Lane March 22, 2024July 16, 2024
Former Cann Group executive Shane Duncan to plot acquisition strategy for Biortica Agrimed by Steve Jones March 13, 2024March 13, 2024
Optimism turns to concern as Cann Group battles financial uncertainty by Steve Jones March 7, 2024March 7, 2024
Cann Group shares suspended as auditor reports ‘insufficient evidence’ of future funding by Steve Jones March 1, 2024March 1, 2024
German legalisation set to ‘open up opportunities’ for Australian firms by Steve Jones February 29, 2024July 16, 2024
Australian cannabis cultivators call for industry support by Martin Lane February 22, 2024July 16, 2024
